Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/29296
Title: Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry
Authors: Martin Murgier,
Laurent Bertoletti,
Michael Darmon,
Fabrice Zeni,
Reina Valle,
Jorge Del Toro,
Pilar Llamas,
Lucia Mazzolai,
Aurora Villalobos,
Monreal, Manuel and the RIETE Investigators
Bosevski, Marijan 
Zdraveska, Marija 
Krstevski, Gregor 
Keywords: Acute kidney injury
Biomarkers
Bleeding
Mortality
Pulmonary embolism
Risk
Issue Date: 2019
Source: Martin Murgier, Laurent Bertoletti, Michael Darmon, Fabrice Zeni, Reina Valle, Jorge Del Toro, Pilar Llamas, Lucia Mazzolai, Aurora Villalobos, Manuel Monreal, Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry, International Journal of Cardiology, Volume 291, 2019,Pages 121-126, ISSN 0167-5273, https://doi.org/10.1016/j.ijcard.2019.04.083.
Journal: International Journal of Cardiology
Abstract: Rationale: Acute kidney injury (AKI) is associated with a poor outcome. Although pulmonary embolism (PE) may promote AKI through renal congestion and/or hemodynamic instability, its frequency and influence on outcome in patients with acute PE have been poorly studied. Methods: The frequency of AKI (defined according to the "Kidney Disease: Improving Global Outcomes" definition) at baseline and its influence on the 30-day mortality was evaluated in patients with acute PE from the RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry. We used multivariate analysis to assess whether the presence of AKI influenced the risk for 30-day death. Results: The study included 21,131 patients, of whom 6222 (29.5%) had AKI at baseline: 4385 patients (21%) in stage 1, 1385 (6.5%) in stage 2 and 452 (2%) in stage 3. The proportion of patients with high-risk PE in those with no AKI, AKI stage 1, AKI stage 2 or AKI stage 3 was: 2.8%, 5.3%, 8.8% and 12%, respectively (p < 0.001). After 30 days, 1236 patients (5.9%) died. Overall mortality was 4% in patients with no AKI, 8.4% in AKI stage 1, 14% in AKI stage 2 and 17% in AKI stage 3 (all p < 0.001). AKI was independently associated with an increased risk of all-cause death at 30 days (odds ratio = 1.25; 95%CI: 1.02-1.54). Conclusions: One in every 3-4 patients with acute PE had AKI at baseline. The presence of AKI independently predicted 30-day mortality. This study suggests that AKI may deserve to be evaluated as a prognostic factor in patients with acute PE.
URI: http://hdl.handle.net/20.500.12188/29296
DOI: 10.1016/j.ijcard.2019.04.083
Appears in Collections:Faculty of Medicine: Journal Articles

Files in This Item:
File Description SizeFormat 
2019, murgier kidney injury.pdf560.67 kBAdobe PDFView/Open
Show full item record

Page view(s)

21
checked on May 3, 2024

Download(s)

4
checked on May 3, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.